Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 2
1988 1
1990 1
1996 1
1997 1
1999 4
2000 5
2001 1
2002 4
2003 4
2004 6
2005 7
2006 7
2007 8
2008 12
2009 15
2010 23
2011 31
2012 21
2013 27
2014 24
2015 10
2016 8
2017 12
2018 10
2019 8
2020 6
2021 3
2022 4
2023 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

219 results

Results by year

Filters applied: . Clear all
Page 1
The Human Bitumen Study: executive summary.
Raulf-Heimsoth M, Pesch B, Rühl R, Brüning T. Raulf-Heimsoth M, et al. Among authors: pesch b. Arch Toxicol. 2011 Jun;85 Suppl 1:S3-9. doi: 10.1007/s00204-011-0679-0. Epub 2011 Mar 3. Arch Toxicol. 2011. PMID: 21369765 Review.
NAT2 and bladder cancer--response.
Pesch B, Bruening T, Vineis P. Pesch B, et al. Cancer Epidemiol Biomarkers Prev. 2014 Mar;23(3):562. doi: 10.1158/1055-9965.EPI-13-1349. Epub 2013 Dec 31. Cancer Epidemiol Biomarkers Prev. 2014. PMID: 24381185 No abstract available.
Considerations of circadian impact for defining 'shift work' in cancer studies: IARC Working Group Report.
Stevens RG, Hansen J, Costa G, Haus E, Kauppinen T, Aronson KJ, Castaño-Vinyals G, Davis S, Frings-Dresen MH, Fritschi L, Kogevinas M, Kogi K, Lie JA, Lowden A, Peplonska B, Pesch B, Pukkala E, Schernhammer E, Travis RC, Vermeulen R, Zheng T, Cogliano V, Straif K. Stevens RG, et al. Among authors: pesch b. Occup Environ Med. 2011 Feb;68(2):154-62. doi: 10.1136/oem.2009.053512. Epub 2010 Oct 20. Occup Environ Med. 2011. PMID: 20962033
Toward noninvasive follow-up of low-risk bladder cancer - Rationale and concept of the UroFollow trial.
Benderska-Söder N, Hovanec J, Pesch B, Goebell PJ, Roghmann F, Noldus J, Rabinovich J, Wichert K, Gleichenhagen J, Käfferlein HU, Köhler CU, Johnen G, Kernig K, Hakenberg O, Jahn D, Todenhöfer T, Stenzl A, Gleissner J, Gerwert K, El-Mashtoly S, Behrens T, Brüning T, Schmitz-Dräger BJ. Benderska-Söder N, et al. Among authors: pesch b. Urol Oncol. 2020 Dec;38(12):886-895. doi: 10.1016/j.urolonc.2020.01.006. Epub 2020 Mar 18. Urol Oncol. 2020. PMID: 32199755 Review.
Occupational exposure to nickel and hexavalent chromium and the risk of lung cancer in a pooled analysis of case-control studies (SYNERGY).
Behrens T, Ge C, Vermeulen R, Kendzia B, Olsson A, Schüz J, Kromhout H, Pesch B, Peters S, Portengen L, Gustavsson P, Mirabelli D, Guénel P, Luce D, Consonni D, Caporaso NE, Landi MT, Field JK, Karrasch S, Wichmann HE, Siemiatycki J, Parent ME, Richiardi L, Simonato L, Jöckel KH, Ahrens W, Pohlabeln H, Fernández-Tardón G, Zaridze D, McLaughlin JR, Demers PA, Świątkowska B, Lissowska J, Pándics T, Fabianova E, Mates D, Bencko V, Foretova L, Janout V, Boffetta P, Bueno-de-Mesquita B, Forastiere F, Straif K, Brüning T. Behrens T, et al. Among authors: pesch b. Int J Cancer. 2023 Feb 15;152(4):645-660. doi: 10.1002/ijc.34272. Epub 2022 Sep 23. Int J Cancer. 2023. PMID: 36054442 Free article.
Considerations on the use of urine markers in the management of patients with high-grade non-muscle-invasive bladder cancer.
Kamat AM, Vlahou A, Taylor JA, Hudson ML, Pesch B, Ingersoll MA, Todenhöfer T, van Rhijn B, Kassouf W, Barton Grossman H, Behrens T, Chandra A, Goebell PJ, Palou J, Sanchez-Carbayo M, Schmitz-Dräger BJ. Kamat AM, et al. Among authors: pesch b. Urol Oncol. 2014 Oct;32(7):1069-77. doi: 10.1016/j.urolonc.2014.06.017. Epub 2014 Oct 11. Urol Oncol. 2014. PMID: 25306288 Review.
Calretinin as a blood-based biomarker for mesothelioma.
Johnen G, Gawrych K, Raiko I, Casjens S, Pesch B, Weber DG, Taeger D, Lehnert M, Kollmeier J, Bauer T, Musk AW, Robinson BWS, Brüning T, Creaney J. Johnen G, et al. Among authors: pesch b. BMC Cancer. 2017 May 30;17(1):386. doi: 10.1186/s12885-017-3375-5. BMC Cancer. 2017. PMID: 28558669 Free PMC article.
219 results